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Abstract
Background: Pneumonia remains a leading cause of child death in developing countries. The viruses in severe
pneumonia remain poorly defined.
Methods: The study was conducted at the Eastern Visayas Regional Medical Center in Tacloban City, Philippines
from May 2008 to May 2009. Patients aged 8 days to 13 years old who were admitted to the Department of
Pediatrics with severe pneumonia were enrolled for the study. Upon admission, polymerase chain reaction was
performed using nasopharyngeal swabs and blood cultures to detect respiratory viruses and bacteria, respectively.
Result: Among the 819 patients enrolled, at least one virus was detected in 501 cases (61.2%). In addition, 423
cases were positive for a single virus while bacteria were detected in the blood culture sample of 31 cases. The
most commonly detected viruses were human rhinoviruses (n = 189), including types A (n = 103), B (n = 17), and C
(n = 69), and respiratory syncytial virus (RSV) (n = 165). Novel viruses such as human metapneumovirus, human
coronavirus NL63, human bocavirus, and human polyomaviruses WU and KI were also detected. There were 70
deaths, and one or more viruses were detected in 35 (50%) of these cases. Positivity only for influenza A virus (OR =
4.3, 95% CI = 1.3-14.6) was significantly associated with fatal outcome. From the blood culture, Burkholderia cepacia
group (n = 9), Streptococcus pneumoniae (n = 4), Staphylococcus aureus (n = 4), Haemophilus influenzae (n = 1), and
Salmonella C1 (n = 1) were also isolated.
Conclusion: Viruses were commonly detected in children with severe pneumonia in the Philippines. Hence, viral
etiologies should be considered while developing better effective strategies to reduce child pneumonia-related
deaths in developing countries.
Background
Infant and under-five mortality rates are commonly con-
sidered as important health indicators. In 2000, the United
Nations introduced the Millennium Development Goal 4
(MDG4) to reduce under-five mortality by two-thirds be-
tween 1990 and 2015. The under-five mortality rate has
steadily decreased from 90 per 1000 live births in 1990 to
65 per 1000 live births in 2008 [1]. However, the rate
remains high in many developing countries[1], and pneu-
monia is still the leading cause of childhood mortality [2,3],
particularly in the developing countries. It is estimated that
approximately 2 million children die from pneumonia an-
nually, and 90% of these deaths occur in developing
countries [2-4]. However, viral etiologies may be underesti-
mated in cases of severe pneumonia in the resource-
limited countries with limited diagnostic facilities. The role
of viral pathogens in severe pneumonia has come into
prominence as the role of bacterial infection decreases
through early case detection, appropriate antibiotic treat-
ment [5] and introduction of conjugate vaccines.
Historically, the common viruses most closely associated
with childhood pneumonia have included influenza virus
(Flu), respiratory syncytial virus (RSV), parainfluenza virus
(PIV), and adenovirus (AdV). The development of mo-
lecular techniques facilitated the detection of novel viruses
in patients with respiratory infections. Human metapneu-
movirus (hMPV) was first documented in 2001 [6]. Since
then, a series of human coronaviruses (HCoVs), including
NL-63 [7], -NH [8], and -HKU-1 [9], a new genogroup of
human rhinoviruses (HRVs) called type-C rhinoviruses
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[10], human bocavirus (HBoV) [11], and human polyoma-
viruses WU (WUV) and KI (KIV) [12,13] have been
reported. We recently demonstrated the presence of
hMPV, HCoV-NL63, HCoV-HKU1, HBoV, WUV, and
KIV in patients with influenza-like illness in the Philip-
pines [14], but were unable to assess their clinical signifi-
cance in children with pneumonia. The etiological roles of
these novel viruses remain undefined.
In this prospective study, we investigated the association
between presence of a virus and severity of disease in hos-
pitalized children with severe pneumonia to provide an in-
dication of causality. With this aim, we detected viral as
well as bacterial pathogens in children hospitalized with
severe community-acquired pneumonia and assessed the
clinical significance of these pathogens.
Methods
Study site
The study was conducted at the Eastern Visayas Regional
Medical Center (EVRMC) in Tacloban City, Philippines.
Tacloban City is the capital of Leyte Province and the re-
gional center for Region VIII, also known as “Eastern
Visayas”. The climate of Leyte Province is classified as
tropical monsoon, and it usually rains throughout the year
with higher rainfall between November and January. Re-
gion VIII consists of two main islands, Leyte and Samar,
with a population of approximately 4 million (See Add-
itional file 1a and b: Map of the Philippines and Region
VIII). This region is generally economically less developed,
and the estimated poverty incidence (the proportion of
people in the population whose income is lesser than the
cost of basic needs) was 40.7%, compared to the national
estimate of 26.9% [15]. The estimated under-five mortality
rate in 2008 was 64 per 1000 live births in Region VIII,
which is significantly higher than the national average of
28 deaths per 1000 live births in urban areas and 46
deaths per 1000 live births in rural areas of the Philippines
[16]. EVRMC has a 250-bed capacity including 50
pediatric beds and is the only tertiary care government
hospital in Region VIII. Patients were referred from all
over the region, but majority of the patients were from
Leyte Province, particularly from Tacloban City.
Study patients and case definitions
From May 2008 to May 2009, patients aged 8 days to 13
years old who visited the Emergency Room of EVRMC
and presented with acute respiratory infection were evalu-
ated according to IMCI guidelines [17]. Patients assessed
to have severe pneumonia requiring hospitalization were
recruited for participation in the study. The definition of
severe pneumonia was based on IMCI guidelines. All
cases were screened with the presence of cough or diffi-
culty of breathing as the initial assessment. For patients
between 8 days to less than 2 months old, entry criteria
included fast breathing (more than 60 breaths/min), chest
indrawing, cyanosis, or an inability to drink or suck. For
patients between 2 months to less than 5 years old, entry
criteria included chest indrawing, cyanosis, or an inability
to drink or suck. For patients between 5 to 13 years old,
entry criteria included co-morbid illness (including mal-
nutrition), failure to feed, moderate to severe dehydration,
signs of respiratory failure (chest indrawing, cyanosis,
apnea, or sensorial change), or complications such as
plural effusion and pneumothorax. The exclusion criteria
included patients less than 7 days old to exclude perinatal
infection, patients admitted to any other department of
EVRMC for another illness and who had developed symp-
toms of pneumonia while in hospital, or patients who had
been admitted to another hospital within the last 3 days
prior to present admission to EVRMC to exclude nosoco-
mial infection.
This was a prospective observational study. The anti-
biotics provided were based on the guidelines of the
Philippine Pediatric Society [18]. As supportive therapy,
oxygen was provided using a nasal catheter or oxygen
mask. Endotracheal intubation was done if necessary
and hooked to a manual ambu bag as there was no
mechanical ventilator in the pediatric ICU of EVRMC.
Patient information
The staff of the Pediatric Department were retrained on
the IMCI-Acute Respiratory Infection case management
protocol prior to initiation of the study [19]. Trained
project pediatricians and nurses collected relevant clin-
ical information on admission including information on
antibiotics administered during the current episode.
They also recorded signs, symptoms and vital signs of
enrolled patients twice a day. Thereafter, patient out-
comes were classified using the following five categories
on the basis of their condition on discharge: “Discharged
improved,” “Discharged against medical advice-
Improved,” “Discharged against medical advice-deterior-
ating,” “Died,” and “Others.” “Others” included those
who absconded or were transferred to another hospital.
For data analysis, we combined “Discharged against
medical advice-deteriorating” and “Died” as the fatal or
life-threatening outcome group as we did in previous
“Bohol study” in the Philippines [20-22].
Radiological assessment
Anteroposterior and lateral chest radiographs were taken
upon admission. Interpretation was performed by a
designated radiologist trained in the standard interpret-
ation of chest radiographs for the diagnosis of childhood
pneumonia, as developed by the WHO Pneumonia Vac-
cine Trial Investigators’ Group [23].
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Detection of viruses
Nasopharyngeal swabs were taken from patients using
EX-swab 002 (DENKA SEIKEN, Tokyo, Japan), stirred in
3 ml of viral transport medium (VTM), and stored at 4°C
until sample transport. Swabs were shipped to the Re-
search Institute for Tropical Medicine (RITM) for virus
detection twice a week using the recommended biological
transport containers with temperatures maintained at 4°C.
The specimens were subjected to PCR within 10 days after
sample collection. Common respiratory viruses were tar-
geted. RNA and DNA present in 100 μl of VTM super-
natant were purified using the QIAamp MinElute Virus
Spin Kit (Qiagen, Hilden, Germany). To synthesize com-
plementary DNA, 11 μl of the final extract was used as a
template with superscript III, random hexamers, and
RNase inhibitor (all obtained from Invitrogen, Carlsbad,
CA). PCR was performed to detect FluA, FluB, RSVs,
hMPV, HCoVs, HBoV, WUV, and KIV as previously
described [14]. For PIV-1, -2, and −3, the hemagglutinin-
neuraminidase region was amplified [24]. For HRVs, the
50 noncoding region was amplified using the primer pairs
DK001 [25] and DK004 [26]. Negative and positive con-
trols were added in each PCR run. For the purpose of our
routine quality control, PCR for all positive samples were
double checked in the Department of Virology, Tohoku
University Graduate School of Medicine.
Serotypes or genotypes of RSVs, HRVs, and AdVs were
determined by sequencing the hypervariable region of the
G protein gene for RSVs [27], the VP4-VP2 region of
HRVs [28], and the hexon region of AdVs [29]. Sequen-
cing was performed using ABI 3730xl with BigDye version
1.1 (Applied Biosystems, Carlsbad, CA), and sequence
results were analyzed by MEGA ver. 4 [30] with reference
strains from Genbank.
Detection of bacteria
Blood culture for bacteria was performed by trained med-
ical technologists in EVRMC as previously described [22].
On admission, 1 ml of venous blood was collected aseptic-
ally and inoculated into a bottle containing 20 ml of
brain-heart infusion broth with 1% gelatin, 0.125% sodium
polyanethol sulfonate, and 0.1% agar. Samples were incu-
bated at 36°C for seven days and subcultures were made
on sheep blood, chocolate, and MacConkey agar plates
after 18 hours and 3, 5, and 7 days of inoculation. Plates
were cultured at 36°C in a candle jar for 2 days. Drug sen-
sitivity testing for all isolates was performed by the disk
diffusion method based on Clinical Laboratory Standard
Institute (CLSI) guidelines and resistant isolates were
tested by the E-test for minimum inhibitory concentration
(MIC) determination. All isolates were stored in the skim
milk at −20°C and transported to RITM for confirmatory
tests. Final identification was done in the Department of
Microbiology, RITM. This department has been
participating in the College of American Pathologists Pro-
ficiency Tests for Microbiology, and it has consistently
passed the External Quality Assurance System (EQAS)
since 2008. For confirmatory test for Burkholderia cepacia
group, isolates were sent to Miroku Medical Laboratory in
Nagano, Japan, and underwent sequencing for 16S rRNA.
Statistical analysis
All data was encoded into the FileMaker database (File-
Maker CA, USA), and statistical analysis was performed
using SPSS 18.0J (SPSS Japan, Tokyo, Japan). Univariate
analysis was used to determine the viral pathogens asso-
ciated with fatal outcomes. The risk of fatal outcome for
each detected virus and virus combination was evaluated
by estimating the odds ratio (OR) based on categorization
in the “Discharged against medical advice-deteriorating”
or “Died” category.
Ethical consideration
The study protocol was approved by the Institutional
Review Board of Tohoku University Graduate School of
Medicine, RITM, and EVRMC. The parents or guardians
gave written informed consent for their children to par-
ticipate in the study.
Results
Patients' profiles
During the 13-month study period, a total of 1242
patients were screened and 1043 met with the inclusion
criteria. Of the 1043 patients, 224 refused to participate.
A total of 819 cases were subsequently enrolled in the
study. Background information and physical findings of
the 819 cases are summarized in Table 1. Among the
224 patients whose parents or guardians refused enrol-
ment, we collected data only from 48 patients screened
since December 2008. The major reason for the refusal
was that parents did not permit to collect blood samples
from their children (73.0%[35/48]). The ratio of severe
pneumonia (67% [32/48]), very severe pneumonia (23%
[11/48]), and others (10% [5/48]) was 67:23:10. This ratio
was different from that of the enrolled patients (50:44:6).
The median age was 9.0 months, and the age distribu-
tion was skewed towards younger age groups (See Add-
itional file 2: Age distribution of children hospitalized
with severe pneumonia in Eastern Visayas Regional
Medical Center, May 2008 to May 2009).
Wheezing was observed in half of the patients (n = 418,
51.1%). One hundred seventy five patients (21.4%) had
interstitial infiltrates on chest x-ray, and 157 patients
(19.2%) had consolidation. The median time interval be-
tween the onset of illness and admission was 4 days. Fur-
thermore, 32.2% patients (n = 264) had received antibiotics
prior to hospital admission. Since 10.7% (n = 88) of the
cases deteriorated during hospital admission, they were
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classified as “Died” (n = 70, 8.5%) or “Discharged against
medical advice-deteriorating” (n = 18, 2.2%).
Detection of viruses
Among the 819 respiratory samples, 501 samples (61.2%)
were positive for at least one virus. These included 423
cases (51.6%); 72 cases (8.8%); and 6 cases (0.7%) who
were positive for one, two viruses, and three viruses, re-
spectively (Table 2). The most common respiratory virus
detected was HRV (total positive cases, 30.5% [250/819]),
including type A (HRV-A) (total, 17.3% [142/819]), type B
(HRV-B) (total, 3.1% [25/819]), and type C (HRV-C) (total,
10.1% [83/819]). The second most common virus was
RSV (total, 24.1% [198/819]), most commonly subtype A
(RSV-A) (97% [195/198]). Different subtypes of AdVs
(total, 4.0% [33/819]) were detected: AdV-7 (total, 10; sin-
gle, 6), AdV-3 (total, 8; single, 5), AdV-6 (total, 6; single 1),
AdV-2 (total, 2; single, 1), AdV-4 (total, 2; single, 1), AdV-
5 (total, 2; single, 1), Adv-41 (total, 2; single, 0), and Adv-
12 (total, 1; single, 0). All cases of FluA (total, 2.2% [18/
819]) were seasonal influenza A virus (H1N1). In terms of
multiple infection, more than 50% of samples positive for
AdVs (54.5% [18/33]), WUV (64.0% [16/25]), HBoV
(71.4% [5/7]), FluB (72.7% [8/11]), and KIV (75.0% [3/4])
were positive along with other viruses (Table 2).
Seasonality of the viruses
The monthly rainfall precipitation and case counts are
shown in Figure 1. During the study period, the number
of enrolled cases gradually increased and peaked in Octo-
ber, whereas the rainfall increased beginning in October
and peaked in December. For viruses detected in more
than 20 cases, the monthly distributions of single and
multiple virus-positive cases were shown in Figures 2A
−2F. RSV-A positivity peaked in October 2009 concur-
rently with the increase in rainfall in Tacloban City (Fig-
ures 1 and 2A). Conversely, there was a cluster of hMPV-
positive cases in March which was a month of low rainfall
(Figure 2B). Although AdVs were detected intermittently,
there was a peak in the number of AdV cases (n = 11) in
December (Figure 2C) during which AdV-7 (n = 6), AdV-
6 (n = 3), AdV-4 (n = 1), and AdV-12 (n = 1) were
detected. There was a cluster of HRV-B-positive cases at
the same time as the peak of RSV-A positive cases
(Figures 2A and E), whereas HRV-A and HRV-C were
detected throughout the study period (Figures 2D and F).
Associated risk with viral pathogens
Based on previous “Bohol study” in the Philippines, we
combined “Discharged against medical advice-
deteriorating” and “Died” as the fatal outcome group, as
we mentioned earlier, this group denotes the life-
threatening cases. Since EVRMC is the only tertiary care
government hospital in Region VIII and none of the
Table 1 Background and Clinical Information of children
hospitalized with severe pneumonia, Eastern Visayas













7yo or higher 27 3.3%
Initial Diagnosis
Very Severe Pneumonia 364 44.4%
Severe Pneumonia 410 50.1%
Neonatal Pneumonia and others 45 5.5%
Clinical information
Symptoms and Signs on admission
Cough 818 99.9%
Chest indrawing 808 98.7%
Decrease in breath sound* 796 97.3%






interstitial infiltrate 111 13.6%
consolidation 93 11.4%
interstitial infiltrate and consolidation 64 7.8%
Outcome
Discharged 550 67.2%
Discharged against medical advice-
Improved
151 18.4%





Time interval between Onset and Visit#
Median (Interquartile range) 4(3-7) (unit=days)
Antibiotic prior to admission 264 32.2%
Total 819
*Data was missing for one case.
#Data was missing for two cases.
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“Discharged against medical advice-deteriorating” had re-
admitted, those cases were most likely deceased after dis-
charge. The overall case fatality rate (CFR) was 10.7% [88/
819], and one or more viruses were detected in 52.2% [46/
88] of these fatal cases (See Additional file 3: Outcome of
the children hospitalized with severe pneumonia, Eastern
Visayas Regional Medical Center, May 2008 to May 2009).
There were fatalities in FluA-, RSV-A-, hMPV-, HRV-,
HCoV-, and AdV-positive cases. In terms of CFRs among
single virus-positive cases, FluA had the highest CFR
(33.3% [4/12]). The CFR of RSV-A was 7.5% [12/160],
whereas that of hMPV was 5.9% [1/17]. Among HRVs,
HRV-A (14.3% [14/98]) and HRV-B (11.8% [2/17]) had
equivalent CFRs but HRV-C had a lesser CFR (5.6% [4/
71]). There were two cases positive for HCoVs: a patient
with HCoV-OC43 who was classified under the “died” cat-
egory and one with HCoV-NL63 who was classified under
“Discharged against medical advice-deteriorating” cat-
egory. With respect to AdVs, one AdV-7-positive case was
fatal, and two “Discharged against medical advice-
deteriorating” patients were positive for AdV-3 and AdV-
7. There were two fatal cases each involving two viruses.
One case was positive for HRV-A and AdVs, and the other
was positive for HRV-B and RSV-A.
The risk of fatal outcome for each detected virus was
evaluated on the basis of categorization in the “Discharged
against medical advice-deteriorating” or “Died” category.
First, cases with at least one virus (8.6% [43/498]) were
less likely to be associated with fatal outcomes compared
to virus-negative cases (13.9% [42/321]), but there was in-
sufficient evidence of an association between fatal out-
come and detection of at least one respiratory virus (OR =
0.62, 95% CI = 0.5-1.0). Second, the risk of fatal outcome
according to specific viruses was evaluated (Table 3).
Among single virus-positive groups, being positive for
FluA virus (odds = 0.50) was associated with a greater risk
of fatal outcome (OR= 4.3, 95% CI =1.3-14.6) than non-
FluA single virus positive (odds = 0.12).
Blood culture
Blood culture samples were collected from 814 cases, 31
of which (3.8% [31/814]) were positive in blood culture.
Table 2 Detection of viral pathogens from children hospitalized with severe pneumonia, Eastern Visayas Regional
Medical Center, May 2008 to May 2009
FluA FluB RSV-A RSV-B hMPV PIVs HRV-A HRV-B HRV-C HCoV-OC43 HCoV-NL63 AdVs HBoV WU KI
FluA 12 0 1 0 0 0 2 0 1 0 0 1 0 0 0
FluB - 3 0 0 0 0 4 0 3 0 0 0 0 0 0
RSV-A - - 160 0 0 0 13 6 3 0 0 2 1 5 1
RSV-B - - - 5 0 0 0 0 0 0 0 0 0 0 0
hMPV - - - - 17 0 1 0 2 0 0 1 0 0 1
PIVs - - - - - 8 1 0 0 0 0 1 0 1 0
HRV-A - - - - - - 103 0 0 0 0 5 2 7 0
HRV-B - - - - - - - 17 0 0 0 0 1 1 0
HRV-C - - - - - - - - 69 0 1 2 1 0 0
HCoV-OC43 - - - - - - - - - 1 0 0 0 0 0
HCoV-NL63 - - - - - - - - - - 1 0 0 0 0
AdVs - - - - - - - - - - - 15 0 0 1
HBoV - - - - - - - - - - - - 2 0 0
WUV - - - - - - - - - - - - - 9 0
KIV - - - - - - - - - - - - - - 1
Single virus
positive
423 12 3 160 5 17 8 103 17 69 1 1 15 2 9 1
Double virus
positive
72 5 7 32 0 5 3 35 8 13 0 1 13 5 14 3
Triple viruses
positive
6 1 1 1 0 1 1 4 0 1 0 0 5 0 2 1
Total Positive
Samples
501 18 11 193 5 23 12 142 25 83 1 2 33 7 25 5
Flu indicates influenzavirus; RSV, respiratory syncytial virus; hMPV, human metapneumovirus; PIV, parainfluenzavirus; HRV, human rhinovirus; HCoV, human
coronavirus; AdVs, adenoviruses; HBoV, human bovavirus; WUV, human WU polyomavirus; KVI; human KI polyomavirus.
PIVs-positive cases consisted of 11 cases of PIV-3(single=7) and 1 case of PIV-1(single=1).
Detection of Triple viruses: FluA, HRv-A, and PIV=1 case, FluB, HRV-C, and AdV-5=1 case, hMPV, AdV, and KIV=1case, HRV-A, AdV,and WUV=2 cases, HRV-A, RSV-A,
and AdV=1 case.
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Among gram-positive cocci (n = 15), there were Strept-
coccus pneumonia (n = 4), Staphylococcus aureus (n = 4),
Staphylococcus lugdunesis (n = 3), Staphylococcus epider-
midis (n = 2), and Staphylococcus haemolyticus (n = 2).
Two isolates of S. aureus were methicillin resistant
Staphylococcus aureus (MRSA). For gram-negative rods
(n = 3), there was one case for Haemophilus influenza,
Enterobacter cloacae, and Salmonella C1. For glucose
non-fermentes gram-negative rods (n = 12), there
were Burkholderia cepacia group (n = 9), Pseudomonas
aeruginosa (n = 1), Pseudomonas stutzeri (n = 1), and
Shewanella putrefaciens (n = 1). We confirmed isolation
of Burkholderia cepacia group by 16S rRNA sequencing.
For gram-positive rods, there was Bacillus species (n = 1).
There were four fatal cases among bacterial culture-
positive cases, including B. cepacia group (n = 3)
and MRSA (n = 1), and one “Discharged against
medical advice-deteriorating” case that was positive for
MRSA (n = 1). There were concomitant viral infections
in samples positive for S. pneumoniae (FluB and HRV-A,
n = 1), S. aureus (HRV-C and RSV-A, n = 1; RSV-A and
KIV, n = 1), MRSA (HRV-A, n = 2; HRV-A and AdV-2,
n = 1), H. influenzae (HRV-A, n = 1), and P. aeruginosa
(RSV-A, n = 1).
Discussion
Our study highlighted the potential importance of
viruses as pathogens of community-acquired pneumonia
among hospitalized children in the Philippines. The CFR
in our study setting was as high as 8%, which indicated
that childhood pneumonia is still an important cause of
death in the Philippines. We conducted our current
study following the IMCI guideline, because IMCI has
been implemented in various developing countries for
nearly 20 years [31] as well as we also investigated the
causative pathogens in those hospitalized children. Be-
cause, the IMCI approach toward childhood pneumonia
focuses on bacterial infection, mainly through the empir-
ical use of antibacterial drugs; however, the approach to
the management of viral infections is not included in
IMCI [19]. Furthermore, IMCI was developed on the
basis of etiological studies conducted before 1990, when
the detection methods for viral pathogens were subopti-
mal [32-34]. However, modern molecular methods, such
as PCR exhibits higher sensitivity in virus detection. In
addition, these methods facilitate the discovery of several
new viruses as possible etiological agents for respiratory
infection [6-13]. Using these methods, at least one virus




























































Figure 1 Monthly Distribution of samples collected from children hospitalized with severe pneumonia, cases positive for viruses, and
rainfall precipitation and temperatures (maximum and minimum) in Eastern Visayas Regional Medical Center, May 2008 to May 2009.
The data of the rainfall and temperature was provided by Philippines Atmospheric, Geophysical and Astronomical Service Administration.
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etiological studies also detected viruses in more than
50% of cases in similar settings [35,36].
Although we have demonstrated an important poten-
tial role of viral pathogens, economical and effective
options for the prevention and treatment of viral infec-
tions that are practical to implement in developing
countries are unavailable. HRV- and RSV-positive cases
accounted for approximately 55% of our study popula-
tion and had significant effects including those on mor-
tality. However, no effective and safe vaccines or
antiviral drugs for these viruses are currently available
[37]. The monoclonal RSV antibody for prophylaxis has
been used for high-risk infants in developed countries,
but this antibody is far too expensive to be used in
developing countries [38]. FluA had the highest CFR and
was a significant risk factor for fatal outcome, which
suggests its potential high mortality impact during larger
epidemics. Antiviral drugs such as neuraminidase inhibi-
tors and vaccines for influenza are widely available and
used in developed countries; however, they are not af-
fordable in most of the developing countries [39]. To re-
duce childhood mortality due to viral pneumonia,
feasible and inexpensive management strategies, such as
triaging hypoxic patients with using a pulse oximeter
and administering early treatment with oxygen, should
be urgently developed [40].
Although we previously demonstrated the presence of
novel viruses in the Philippines [14], our current study
provided additional insight on novel viruses. One of the
significant findings was the detection of HRV-C. In pre-
vious studies, the impact of HRV-C on morbidity and
mortality was similar to that of HRV-A and was much



































































































































































































































































































































































Figure 2 Monthly distribution of RSV-A(A), hMPV(B), AdVs(C), HRV-A(D), HRV-B(E), and HRV-C(F). RSV indicates respiratory syncytial virus;
hMPV, human metapneumovirus; AdVs, adenoviruses; HRV, human rhinovirus.
Table 3 Odds and odds ratio for being fatal outcome#
among children hospitalized with severe pneumonia,











FluA 4/12 0.50 0/6 0.00 84/801 0.12 4.3(1.3-14.6)
RSV-A 12/160 0.08 1/33 0.03 75/626 0.14 0.6(0.3-1.2)
hMPV 1/17 0.06 0/6 0.00 87/796 0.12 0.5(0.1-3.9)
HRV-A 15/103 0.17 2/39 0.05 71/677 0.12 1.5(0.9-2.7)
HRV-B 2/17 0.13 1/8 0.14 85/794 0.12 1.1(0.3-4.9)
HRV-C 4/69 0.06 0/14 0.00 84/736 0.13 0.5(0.2-1.4)
AdVs 3/15 0.25 2/18 0.13 83/786 0.12 2.1(0.6-7.6)
Flu indicates influenzavirus; RSV, respiratory syncytial virus; hMPV, human
metapneumovirus; HRV, human rhinovirus; AdVs, adenoviruses.
#Fatal outcome is defined as either in “Discharged against medical advice-
Deteriorated” or “Died”.
$Single virus positive cases for the virus were compared with all other cases
which may include multiple virus positive and virus negative cases.
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HRV-C, the prevalence of which was less than that of
HRV-A and greater than that of HRV-B, was detected in
10.1% of the total cases and in three fatal cases. These
results suggest that HRV-C could be an important viral
pathogen in the cause of severe childhood pneumonia in
the Philippines. However, its etiological role is still con-
troversial because this virus has also been detected in
healthy individuals [42]. Further studies are necessary to
define the role of HRV-C in childhood pneumonia. An-
other novel virus that shares similar epidemiological and
clinical features with RSV in industrialized countries is
hMPV [44]. Previous studies in other developing coun-
tries indicated that the incidence of hMPV was lower
than that of RSV [35,36,45]. However, we observed a
fatal case of hMPV which might have an impact in
our study setting. A series of HCoVs have been discov-
ered by recent techniques [7-9]. Although none of the
HCoV-positive cases exhibited improvement during
hospitalization, the number of positive cases was very
small. Conversely, there was no fatal case among those
positive for newly discovered DNA viruses including
HBoV, WUV, and KIV which suggest that their impact
in our study is insignificant. However, their severity
should be carefully interpreted because of the small
number of positive cases for these viruses.
Studies on childhood pneumonia were conducted in
the Philippines in the 1980s and 1990s [32,33,46]. In
addition to those previous studies, subtyping of viral
genetic information revealed group-specific epidemi-
ology. Tupasi et al. demonstrated that RSV was the most
common viral cause among children admitted with acute
lower respiratory infection in the Philippines [33]. This
was consistent with our present study as well as with
other recent studies in developing countries
[35,36,45,47]. RSV can be classified into two major
groups; however, their proportions may change during
epidemics [48]. Similarly, we demonstrated that the in-
crease in the number of cases between September and
December 2008 was primarily due to RSV-A, although
RSV-B was also present in the early stage of the epi-
demic. We may further need to assess the RSV itself to
understand the circulation dynamics of the virus [49].
On the contrary, Capeding et al. demonstrated that
AdVs were also important viral pathogens in the Philip-
pines [46]. We observed clustering of AdV-7 in genus B
and AdV-6 in genus C, both of which are known to
cause respiratory infections of varying severities among
children [50]. As each genus of AdVs has different clin-
ical and epidemiological features [51], genetic classifica-
tion will help us understand the epidemiology of AdVs
in tropical climates.
Bacteremia was observed in 3.8% of our cases, and this
rate is similar to our previous findings in the Philippines
(2.9% and 5%) [20,22]. In addition to two major
bacterial pathogens, S. pneumoniae (n = 4) and H.
influenzae (n = 1), the most commonly isolated bacteria
was B. cepacia group (n = 9). B. cepacia is a habitant of
the natural environment, but can cause severe infection
in the hospital settings especially among immunocom-
promised patients in ICU [52,53]. Since B. cepacia infec-
tion in the community is rare [54,55] and the samples
were collected upon admission, it is more likely that
those isolates of B. cepacia group are the contaminants
due to contaminated sampling devices, such as disinfec-
tant products [56], rather than causative bacteria patho-
gen for the pneumonia. However, it should be noted that
3 of those B. cepacia group positive-cases died. However,
further investigation on the pathogenicity of the B. cepa-
cia in our study setting is required.
We might have underestimated the incidence of bac-
terial pneumonia since prior antibiotic use was observed
among 32.4% [264/814] of the enrolled cases. However,
a recent study indicated that the prevalence of
bacteremia among children with community-acquired
pneumonia in the emergency department was as low as
2.1% [57]. Unlike viral isolation, there is no “gold stand-
ard” for the diagnosis of bacterial pneumonia among
children [58]. Blood culture is widely performed, but its
sensitivity is as low as 1-3% [59]. Bacteria cultured from
the nasopharynx or throat do not always represent the
pathogens in the lungs, as it may include the normal
flora of the nose or throat. Lung tap provides an accur-
ate diagnosis of childhood pneumonia [60], but it is an
invasive procedure, difficult to perform aseptically, and
therefore it is not commonly practiced in developing
countries to avoid any iatrogenic complication due to
the procedure itself.
The treatment approach of IMCI recommends the
empirical use of antibacterial drugs [19], but there is a
dilemma of the overuse of antibiotics that increases the
emergence of drug resistance. Moreover, antibiotics can
be purchased without prescription in the Philippines.
For S. pneumoniae, all three invasive isolates were sus-
ceptible to penicillin, as reported in a previous study in
Bohol, Philippines [61]. However, two cases with MRSA
did not exhibited improvement during hospitalization.
Community-acquired MRSA is a growing problem in
developing countries [62]. As IMCI encourages vaccine
and antibiotic use for bacterial infections, continuous
monitoring of serotype distribution and drug susceptibil-
ity is essential for devising a local and cost-effective
strategy against childhood pneumonia.
There are some limitations of our study. Firstly, the de-
tection of viruses by molecular techniques may not neces-
sarily indicate that the detected virus is a causative agent
of respiratory symptoms since it does not fulfill Koch’s
postulate. We understand that the gold standard for the
diagnosis of viral infection is virus isolation; however,
Suzuki et al. BMC Infectious Diseases 2012, 12:267 Page 8 of 11
http://www.biomedcentral.com/1471-2334/12/267
many novel viruses cannot be isolated, and demonstrating
the presence of the viral genome is the only available de-
tection method. On the other hand, we identified multiple
viruses in different combinations especially among
patients positive for HBoV, WUV, and KIV (Table 2).
WUV and KIV are members of Polyomaviridae that fre-
quently cause latent infection along with reactivation by
immunosupression [63]. Their pathogenicity needs to be
elucidated with further epidemiological and clinical stud-
ies including appropriate “healthy” control groups. Se-
condly, we were not able to obtain the demographic
information of those who refused to participate in the
study due to ethical concerns. The proportion of very se-
vere pneumonia among those who refused to participate
was smaller than that of admitted cases, which may have
led to an underestimation of the severity of the disease.
Thirdly, our study was conducted in the only referral hos-
pital in the region. Therefore, our study population may
represent only severe and very severe cases with access to
healthcare facilities in the study area. This may have
resulted in the underestimation of some etiologies. FluA
had the highest CFR, but its prevalence was low. This may
be due to the reason that the time interval between onset
and admission was 4 days, whereas the viral titer of FluA
in respiratory specimens was highest within 48 hours of
onset [64].
Conclusion
Our study demonstrates a potentially important role for
viral pathogens in the etiology of severe pneumonia
among the children in the Philippines. Our findings sug-
gest that viral etiologies should be always kept in mind
while developing effective strategies to reduce child
pneumonia-related deaths in developing countries.
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